439 related articles for article (PubMed ID: 23552802)
1. Three-month stability of the CogState brief battery in healthy older adults, mild cognitive impairment, and Alzheimer's disease: results from the Australian Imaging, Biomarkers, and Lifestyle-rate of change substudy (AIBL-ROCS).
Lim YY; Jaeger J; Harrington K; Ashwood T; Ellis KA; Stöffler A; Szoeke C; Lachovitzki R; Martins RN; Villemagne VL; Bush A; Masters CL; Rowe CC; Ames D; Darby D; Maruff P
Arch Clin Neuropsychol; 2013 Jun; 28(4):320-30. PubMed ID: 23552802
[TBL] [Abstract][Full Text] [Related]
2. Use of the CogState Brief Battery in the assessment of Alzheimer's disease related cognitive impairment in the Australian Imaging, Biomarkers and Lifestyle (AIBL) study.
Lim YY; Ellis KA; Harrington K; Ames D; Martins RN; Masters CL; Rowe C; Savage G; Szoeke C; Darby D; Maruff P; The Aibl Research Group
J Clin Exp Neuropsychol; 2012; 34(4):345-58. PubMed ID: 22248010
[TBL] [Abstract][Full Text] [Related]
3. Rates of diagnostic transition and cognitive change at 18-month follow-up among 1,112 participants in the Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing (AIBL).
Ellis KA; Szoeke C; Bush AI; Darby D; Graham PL; Lautenschlager NT; Macaulay SL; Martins RN; Maruff P; Masters CL; McBride SJ; Pike KE; Rainey-Smith SR; Rembach A; Robertson J; Rowe CC; Savage G; Villemagne VL; Woodward M; Wilson W; Zhang P; Ames D;
Int Psychogeriatr; 2014 Apr; 26(4):543-54. PubMed ID: 24252258
[TBL] [Abstract][Full Text] [Related]
4. Cognitive decline in adults with amnestic mild cognitive impairment and high amyloid-β: prodromal Alzheimer's disease?
Lim YY; Ellis KA; Harrington K; Pietrzak RH; Gale J; Ames D; Bush AI; Darby D; Martins RN; Masters CL; Rowe CC; Savage G; Szoeke C; Villemagne VL; Maruff P
J Alzheimers Dis; 2013; 33(4):1167-76. PubMed ID: 23160011
[TBL] [Abstract][Full Text] [Related]
5. Effect of amyloid on memory and non-memory decline from preclinical to clinical Alzheimer's disease.
Lim YY; Maruff P; Pietrzak RH; Ames D; Ellis KA; Harrington K; Lautenschlager NT; Szoeke C; Martins RN; Masters CL; Villemagne VL; Rowe CC;
Brain; 2014 Jan; 137(Pt 1):221-31. PubMed ID: 24176981
[TBL] [Abstract][Full Text] [Related]
6. Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: a voxelwise PiB-PET longitudinal study.
Villain N; Chételat G; Grassiot B; Bourgeat P; Jones G; Ellis KA; Ames D; Martins RN; Eustache F; Salvado O; Masters CL; Rowe CC; Villemagne VL;
Brain; 2012 Jul; 135(Pt 7):2126-39. PubMed ID: 22628162
[TBL] [Abstract][Full Text] [Related]
7. Amyloid-β related memory decline is not associated with subjective or informant rated cognitive impairment in healthy adults.
Hollands S; Lim YY; Buckley R; Pietrzak RH; Snyder PJ; Ames D; Ellis KA; Harrington K; Lautenschlager N; Martins RN; Masters CL; Villemagne VL; Rowe CC; Maruff P
J Alzheimers Dis; 2015; 43(2):677-86. PubMed ID: 25114076
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic and Prognostic Accuracy of the Cogstate Brief Battery and Auditory Verbal Learning Test in Preclinical Alzheimer's Disease and Incident Mild Cognitive Impairment: Implications for Defining Subtle Objective Cognitive Impairment.
Stricker NH; Lundt ES; Albertson SM; Machulda MM; Pudumjee SB; Kremers WK; Jack CR; Knopman DS; Petersen RC; Mielke MM
J Alzheimers Dis; 2020; 76(1):261-274. PubMed ID: 32538841
[TBL] [Abstract][Full Text] [Related]
9. Addressing population aging and Alzheimer's disease through the Australian imaging biomarkers and lifestyle study: collaboration with the Alzheimer's Disease Neuroimaging Initiative.
Ellis KA; Rowe CC; Villemagne VL; Martins RN; Masters CL; Salvado O; Szoeke C; Ames D;
Alzheimers Dement; 2010 May; 6(3):291-6. PubMed ID: 20451879
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal Cognitive Decline in Patients With Mild Cognitive Impairment or Dementia Due to Alzheimer's Disease.
Lim YY; Kong J; Maruff P; Jaeger J; Huang E; Ratti E
J Prev Alzheimers Dis; 2022; 9(1):178-183. PubMed ID: 35098989
[TBL] [Abstract][Full Text] [Related]
11. The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease.
Ellis KA; Bush AI; Darby D; De Fazio D; Foster J; Hudson P; Lautenschlager NT; Lenzo N; Martins RN; Maruff P; Masters C; Milner A; Pike K; Rowe C; Savage G; Szoeke C; Taddei K; Villemagne V; Woodward M; Ames D;
Int Psychogeriatr; 2009 Aug; 21(4):672-87. PubMed ID: 19470201
[TBL] [Abstract][Full Text] [Related]
12. Long-term test-retest reliability of resting-state networks in healthy elderly subjects and with amnestic mild cognitive impairment patients.
Blautzik J; Keeser D; Berman A; Paolini M; Kirsch V; Mueller S; Coates U; Reiser M; Teipel SJ; Meindl T
J Alzheimers Dis; 2013; 34(3):741-54. PubMed ID: 23271315
[TBL] [Abstract][Full Text] [Related]
13. The hard Test Your Memory. Evaluation of a short cognitive test to detect mild Alzheimer's disease and amnestic mild cognitive impairment.
Brown JM; Wiggins J; Dong H; Harvey R; Richardson F; Hunter K; Dawson K; Parker RA
Int J Geriatr Psychiatry; 2014 Mar; 29(3):272-80. PubMed ID: 23929807
[TBL] [Abstract][Full Text] [Related]
14. Basal forebrain atrophy correlates with amyloid β burden in Alzheimer's disease.
Kerbler GM; Fripp J; Rowe CC; Villemagne VL; Salvado O; Rose S; Coulson EJ;
Neuroimage Clin; 2015; 7():105-13. PubMed ID: 25610772
[TBL] [Abstract][Full Text] [Related]
15. Using virtual reality to characterize episodic memory profiles in amnestic mild cognitive impairment and Alzheimer's disease: influence of active and passive encoding.
Plancher G; Tirard A; Gyselinck V; Nicolas S; Piolino P
Neuropsychologia; 2012 Apr; 50(5):592-602. PubMed ID: 22261400
[TBL] [Abstract][Full Text] [Related]
16. Relationships between performance on the Cogstate Brief Battery, neurodegeneration, and Aβ accumulation in cognitively normal older adults and adults with MCI.
Lim YY; Pietrzak RH; Bourgeat P; Ames D; Ellis KA; Rembach A; Harrington K; Salvado O; Martins RN; Snyder PJ; Masters CL; Rowe CC; Villemagne VL; Maruff P
Arch Clin Neuropsychol; 2015 Feb; 30(1):49-58. PubMed ID: 25467942
[TBL] [Abstract][Full Text] [Related]
17. Anxiety symptoms in amnestic mild cognitive impairment are associated with medial temporal atrophy and predict conversion to Alzheimer disease.
Mah L; Binns MA; Steffens DC;
Am J Geriatr Psychiatry; 2015 May; 23(5):466-76. PubMed ID: 25500120
[TBL] [Abstract][Full Text] [Related]
18. Effects of education on the progression of early- versus late-stage mild cognitive impairment.
Ye BS; Seo SW; Cho H; Kim SY; Lee JS; Kim EJ; Lee Y; Back JH; Hong CH; Choi SH; Park KW; Ku BD; Moon SY; Kim S; Han SH; Lee JH; Cheong HK; Na DL
Int Psychogeriatr; 2013 Apr; 25(4):597-606. PubMed ID: 23207181
[TBL] [Abstract][Full Text] [Related]
19. Sensitivity of Individual and Composite Test Scores from the Cogstate Brief Battery to Mild Cognitive Impairment and Dementia Due to Alzheimer's Disease.
White JP; Schembri A; Prenn-Gologranc C; Ondrus M; Katina S; Novak P; Lim YY; Edgar C; Maruff P
J Alzheimers Dis; 2023; 96(4):1781-1799. PubMed ID: 38007647
[TBL] [Abstract][Full Text] [Related]
20. Lack of reliable evidence for a distinctive ε4-related cognitive phenotype that is independent from clinical diagnostic status: findings from the Australian Imaging, Biomarkers and Lifestyle Study.
Foster JK; Albrecht MA; Savage G; Lautenschlager NT; Ellis KA; Maruff P; Szoeke C; Taddei K; Martins R; Masters CL; Ames D;
Brain; 2013 Jul; 136(Pt 7):2201-16. PubMed ID: 23737466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
